Navigation Links
Zannos Grekos, MD to Present Clinical Results of Regenerative Stem Cell Treatments to the Dubai Congress on Anti-Aging and Aesthetic Medicine

Repair Stem Cell Institute touts Grekos' breakthrough in Biomedical Technology

WASHINGTON, Nov. 5 /PRNewswire/ -- The Repair Stem Cell Institute (RSCI; today announced that its Science Advisory Board member Zannos G. Grekos, MD, FAAP will present Emerging Frontiers in Regenerative Stem Cell Therapy: Current Clinical Experience with Autologus Adult Stem Cells in the Treatment of Various End Stage Diseases, at the 2008 Dubai Congress on Anti-Aging and Aesthetic Medicine (DCAAAM) in Dubai, United Arab Emirates on Saturday, November 8, 2008 at 3:00 p.m. UTC. According to RSCI Chairman Don Margolis, "Dr. Grekos is taking his groundbreaking work in regenerative biomedical technology to an international arena that has never before seen the dramatic clinical success achieved with his end-stage disease patients. RSCI is proud to have Dr. Grekos on its advisory board and there isn't a company or an institute in the world with the Repair Stem Cell treatment skills and experience that he and its other members bring."

In this Dubai presentation, Dr. Grekos will illustrate regenerated tissue and repaired function at six months and one year post-treatment with Adult Stem Cells. He will also present preliminary results from patients treated within several days through three month follow up. Results include the existence of viable myocardium where previously heart tissue had been destroyed and blood flow through new vessels generated by the injected Stem Cell population. "We have literally saved the lives of patients who prior to the development of Adult Stem Cell therapy, had no option available to them through medical science," states Grekos. "With a minimally invasive treatment, the risks of which are equal to a cardiac catheterization, we are more than doubling cardiac patients' ejection fraction, improving kidney and pulmonary function, saving limbs from amputation by creating new circulation pathways and most recently reversing the life-threatening effects of metabolic heart disease."

Dr. Grekos plans to also announce upcoming clinical trials with prospective candidates in currently untreated illness classifications, including several neurologically based diseases and macular degeneration.

Dr. Zannos Grekos is an Interventional Cardiologist with a private practice in Florida. He is Chief Medical Officer for Regenocyte Therapeutic, one of the world's leading Adult Stem Cell centers, and is Associate Clinical Professor of Cardiology for Nova Southeastern University. Having collaborated with major international treatment and research centers, he has been active in the development of both research and treatment protocols. In February 2007, he was invited to Washington DC to brief the United States Senate Health Advisory Staff on the current state of stem cell research and therapy.

Paul Schwartz, Chief Operating Officer for Regenocyte Therapeutic, states the company "is extremely pleased with the invitation to speak in Dubai. It is a symbol," Schwartz explains, "of the worldwide medical community's embrace of Dr. Grekos' forging of new territory and the notoriety Regenocyte is rapidly gaining through its amazing treatment results."

About the Repair Stem Cell Institute

The Repair Stem Cell Institute LLC (RSCI) is a global public service firm dedicated to educating the public about repair stem cell/adult stem cell research and treatments worldwide. RSCI was founded in April 2008 and is headquartered in Bangkok, Thailand with offices in Dallas, Texas and Washington, D.C.

About Regenocyte Therapeutic

Regenocyte(TM) Therapeutic LLC is one of the only clinically treating Adult Stem Cell Therapy centers in the world today. An experienced team of Board Certified physicians use cutting edge technology, paralleling that of Universities and major medical facilities, to prolong and improve the quality of life of patients living with diseases including Congestive Heart Failure, Cardiomyopathy, Peripheral Artery Disease, Coronary Artery Disease, Kidney Disease, Ischemic Heart Disease, Pulmonary Disease and Early Senile Dementia. For patient information or consultation, call 866-216-5710.

SOURCE The Repair Stem Cell Institute
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. AtriCure to Present at Thomas Weisel Partners 2007 Healthcare Conference
2. Matrixx Initiatives, Inc. to Present at the Roth Capital Partners 2007 New York Conference
3. BD to Present at the Bear Stearns 20th Annual Healthcare Conference
4. ATS Medical to Present at the 2007 Thomas Weisel Partners Healthcare Conference
5. Omnicell to Present at Thomas Weisel Healthcare Conference 2007
6. AtriCure to Present at Roth Capital Partners 2007 New York Conference
7. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
8. MDS to Present at Thomas Weisel Partners Healthcare Conference
9. Hospira to Present at the Bear Stearns 20th Annual Healthcare Conference on September 11
10. AMICAS to Present at Thomas Weisel Partners Healthcare Conference 2007
11. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
Post Your Comments:
(Date:11/25/2015)... , ... November 25, 2015 , ... On November 10, ... States District Court of Connecticut on behalf of a home health care worker who ... current or former home health care workers employed by Humana, Inc., Humana at Home, ...
(Date:11/25/2015)... ... , ... On November 25, 2015, officials of Narconon Arrowhead , the ... of a new cutting edge recovery program that has been 50 years in the ... alcohol-addicted individuals with the purpose to free addicts from the symptoms and negative behaviors ...
(Date:11/25/2015)... ... , ... SCOTTSDALE, AZ) - Today, Dr. Todd C. ... and non-surgical treatments, announced the expansion of his private practice capabilities with the ... Highly trained and nationally recognized for his natural approach, Dr. Todd Hobgood serves ...
(Date:11/25/2015)... (PRWEB) , ... November 25, 2015 , ... Today, ... on our nation’s roadways has dropped below 10,000 for the first time since 2011. ... in 2013. , According to data released by the National Highway Traffic Safety Administration ...
(Date:11/25/2015)... , ... November 25, 2015 , ... ... of philanthropic seniors, is resulting in a way for homeless people to have ... Schaumburg have launched a new initiative whereby they are repurposing plastic bags into ...
Breaking Medicine News(10 mins):
(Date:11/24/2015)... , November 25, 2015 ... due to repeated failure of IVF cycles. After failure ... was totally dejected and had lost all hopes that she would be able ... Indian miracle child conceived after failure of over 15 ... abroad (UK) before they decided to take one last attempt with ...
(Date:11/24/2015)... SAN CARLOS, Calif. , Nov. 24, ... ), a leader in non-invasive genetic testing ... today announced that it will present at ... Conference in New York on Wednesday, December 2, 2015 at 1:00 p.m. ... discuss the Company,s financial results, business activities ...
(Date:11/24/2015)... /PRNewswire/ - ESSA Pharma Inc. ("ESSA" or the "Company") ... the first patient has been enrolled in ESSA,s Phase ... metastatic castration-resistant prostate cancer ("mCRPC"). the ... the United States and Canada.  ... trial, ESSA intends to demonstrate the safety, tolerability, maximum ...
Breaking Medicine Technology: